体外成熟的未来潜力及生育力保存
本综述基于人类卵母细胞与卵泡液研究,梳理支持发展人类体外成熟(IVM)的新证据,包括卵母细胞直径、卵泡大小、促性腺激素水平及卵丘-卵母细胞复合体分泌因子;并指出小滴培养液可模拟体内卵泡激素环境,认为持续研究有望建立与其他哺乳动物同等有效的人类IVM平台。
要点
- 人类IVM受限主要在于获取未成熟卵母细胞困难及女性卵母细胞成熟调控独特。
- 卵巢皮质冷冻保存使髓质小窦卵泡的未成熟卵母细胞可用于人类IVM研究。
- 小滴培养液可模拟体内卵泡激素环境,可能促进卵母细胞核与胞质成熟。
核心结论
- 人类IVM发展受限主要因未成熟卵母细胞获取有限及女性卵母细胞成熟调控独特;持续研究有望建立与其他哺乳动物同等有效的人类IVM平台。
研究设计与样本
- 综述:基于人类卵巢皮质冷冻保存后髓质小窦卵泡来源的未成熟卵母细胞及人颗粒细胞、卵泡液研究,汇总支持人类IVM发展的证据。
主要发现
- 综述涉及卵母细胞直径、采集未成熟卵母细胞的卵泡大小、加速IVM所需的卵泡刺激素与黄体生成素水平,以及卵丘-卵母细胞复合体分泌因子对成熟方式的影响。
- 基于体内卵泡最终成熟期采集的人颗粒细胞与卵泡液研究,已识别生理条件下活跃的多种信号转导通路与激素水平,为改进现有IVM平台提供新候选与途径。
- 作者提出,IVM所用的小滴培养液可模拟体内由体细胞与卵母细胞形成的卵泡激素环境,并可能用于推进卵母细胞核与胞质成熟。
临床怎么用
- 作者认为,持续的研究投入将建立与其他哺乳动物同等有效的人类IVM平台。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In several mammalian species, oocytes from small antral follicles after in vitro maturation (IVM) are successfully used for procreation. Humans are the exception, mainly because of limited access to immature oocytes and because oocyte maturation is uniquely regulated in women. With the introduction of cryopreservation of the ovarian cortex for fertility preservation, immature oocytes from small antral follicles in the medulla are now available for developing IVM on the basis of actual human studies. This review presents recent findings in favor of developing human IVM, including the oocyte diameter, follicle size from which the immature oocytes are collected, necessary level of follicle-stimulating hormone and luteinizing hormone to accelerate IVM, and secretion of factors from the cumulus-oocyte complex that affect the way oocyte maturation takes place. Furthermore, on the basis of studies in human granulosa cells and follicle fluid collected during the final maturation of follicles in vivo, a number of signal transduction pathways and hormone levels active during physiological conditions have been identified, providing new candidates and ways to improve the current IVM platform. Furthermore, it is suggested that the small droplet of culture medium in which IVM is performed mimics the hormonal milieu within a follicle created by the somatic cells and oocyte in vivo and may be used to advance oocyte nuclear and cytoplasmic maturation. Collectively, we envision that a continued research effort will develop a human IVM platform equally effective as for other mammalian species.
引用
- Cadenas J, la Cour Poulsen L, Mamsen LS, et al. Future potential of in vitro maturation including fertility preservation. Fertil Steril. 2023. PMID: 36702341. doi:10.1016/j.fertnstert.2023.01.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。